Tirzepatide is the first dual glucose-dependent insulinotropic polypeptide (GIP)/GLP- 1 receptor co-agonist approved for the treatment of T2DM in the USA, Europe, and the United Arab Emirates [4]
Many patients who begin Mounjaro for blood sugar control experience profound improvements in appetite stability, portion control, cravings, and metabolic health even before achieving substantial weight reduction
The Takeaway: Your smile isnt just cosmetic, its a window into your overall health
Mounjaro is strictly for type 2 diabetes management, whereas Zepbound is approved for weight management
Utilizing this proprietary asiRNA technology, OliX has developed cell penetrating asiRNA (cp-asiRNA), a therapeutic RNAi platform to effectively target diseases locally, such as hypertrophic scarring, dry and wet age-related macular degeneration (AMD), subretinal fibrosis, idiopathic pulmonary fibrosis (IPF), and neuropathic pain